Current Liabilities
Lease Liability Payments - Due Year Two
Neurocrine Biosciences Lease Liability Payments - Due Year Two increased by 0.2% to $59.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.8%, from $59.20M to $59.70M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ2 2020
Last reportedQ1 2026May 5, 2026
How to read this metric
Provides insight into the company's fixed cost commitments and long-term operational leverage.
Detailed definition
The projected cash payments for operating and finance leases scheduled for the second year following the balance sheet d...
Peer comparison
Standard disclosure for lease maturity profiles.
Metric ID:
lease_liability_payments_due_year_2Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.50M | $17.50M | $17.40M | $17.40M | $17.40M | $15.90M | $17.00M | $17.00M | $34.00M | $34.90M | $34.90M | $59.20M | $59.20M | $59.60M | $59.70M |
| QoQ Change | — | +0.0% | -0.6% | +0.0% | +0.0% | -8.6% | +6.9% | +0.0% | +100.0% | +2.6% | +0.0% | +69.6% | +0.0% | +0.7% | +0.2% |
| YoY Change | — | — | — | -0.6% | -0.6% | -8.6% | -2.3% | -2.3% | +113.8% | +105.3% | +105.3% | +74.1% | +69.6% | +70.8% | +0.8% |
Range$15.90M – $59.70M
CAGR+42.0%
Avg YoY Growth+43.8%
Median YoY Growth+35.2%
Current Streak9 quarters growth
Lease Liability Payments - Due Year Two at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's lease liability payments - due year two?
- Neurocrine Biosciences (NBIX) reported lease liability payments - due year two of $59.70M in Q1 2026.
- How has Neurocrine Biosciences's lease liability payments - due year two changed year-over-year?
- Neurocrine Biosciences's lease liability payments - due year two increased by 0.8% year-over-year, from $59.20M to $59.70M.
- What does lease liability payments - due year two mean?
- The total lease payments due in the second year from now.